Home Tags CBD

Tag: CBD

CBD beverage sales a struggle for major US retailers

5/14/21--Sales of CBD-infused beverages in major U.S. retail chains struggled in the past year, according to new data from analytics firm NielsenIQ. Hemp-derived CBD beverage sales in 30,000 stores across major chains in grocery, drug and select convenience stores tracked by Nielsen were down 32% for the year ending March 27 compared to the same period last year. Read

CBD Co. agrees to pay $500K over health claims

5/10/21-- Cannabis company Cannacraft agrees to pay more than $500,000 in penalties to settle charges brought by a California consumer protection task force accusing it of improperly marketing CBD products as treatment for cancer, Altzheimer's diseases and more. Read

FTCs ‘Operation CBDeceit’: How to understand it and what to watch for going forward

3/24/21--In December 2020, the Federal Trade Commission (FTC) announced proposed settlements with six CBD companies accused of making a broad range of unsubstantiated health claims. Nicknamed “Operation CBDeceit,” the enforcement sweep was part of the FTC’s ongoing effort to protect consumers from false, deceptive, and misleading health claims made in advertisements on websites, through social media, and on other platforms. These settlements became final in early March 2021. Read

Broad-spectrum extract tea maker accused of false THC claim

2/8/21--Total Life Changes of Fair Haven, Michigan, has been sued by a New Jersey man who says the company’s instant Iaso Tea is “intentionally misleading the general public” by carrying a label that says it “contains 0.0% total THC as evidenced through independent laboratory tests.” Read

FDA withdraws pending CBD enforcement proposal

1/25/21--The FDA has withdrawn their proposal to regulate over-the-counter CBD, handing the industry another setback after years of delay from the Food and Drug Administration. The proposal in question was withdrawn because of the changing administration. The delay was widely anticipated but still frustrating for CBD operators awaiting the rules. Read

Better data for a better understanding of the use and safety profile of cannabidiol (CBD) products

1/8/21--The FDA evaluates CBD under a regulatory framework defined by law and with rigorous scientific evidence as a basis for both our regulatory approach and information we communicate. There are still no clear answers to important questions such as what adverse reactions may be associated with CBD products and what risks are associated with the long-term use of CBD products. Therefore, better data in these areas are needed for the FDA and other public health agencies to make informed, science-based decisions that impact public health. Read

EU drug agency flags CBD market issues in report on low-THC cannabis products

12/23/20--The Lisbon-based European Monitoring Centre for Drugs and Drug Addiction published the report on Monday, detailing the results of a study that kicked off in 2018 and aimed to provide insight into the open sale of low-THC products in Europe. Read

FDA warns companies illegally selling CBD products

12/22/20--Today, the U.S. Food and Drug Administration issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). All five warning letters address the illegal marketing of unapproved CBD products claiming to treat medical conditions. Read

CBD drug is approved for a third form of epilepsy

9/15/20--Epidiolex, is the only FDA-approved drug with CBD as an active ingredient, was approved to treat seizures associated with tuberous sclerosis complex (TSC) in patients aged 1 year or older. TSC is a genetic disease that causes benign tumors to grow throughout the body. Read

Pharma company, supplement chain retailer weigh in on CBD during White House meetings

9/28/20--As the hemp industry awaits guidance from food and drug regulators on whether CBD will be permitted to be used as an ingredient in food and dietary supplements, the White House Office of Management and Budget continues to meet with companies and industry advocates to gain insight. Two of those meetings discussing the future of cannabidiol were with CBD drug maker GW Pharmaceuticals and chain retailer General Nutrition Centers (GNC). Read

Charlotte’s Web swings to loss in Q2, citing pandemic and operating expenses

9/14/20--Charlotte’s Web Holdings, a CBD manufacturer in Boulder, Colorado, lost $14.4 million last quarter as the coronavirus pandemic slowed retail sales and operating expenses rose 82% from the same period a year ago. The company announced a plan to reduce operating expenses by 10% by the end of 2020, without elaborating. Read

Canopy Growth’s new online store provides one-stop shop for growing U.S. product portfolio

7/27/20--Canopy Growth Corporation, a world-leading diversified cannabis, hemp, and cannabis device company, today announced the launch of its new U.S. e-commerce website that will serves as the online home for Canopy Growth’s growing portfolio of U.S. hempderived CBD product lines, and a one-stop shop for over 25 products. Read

FDA issues draft guidance on cannabis research

7/22/20--The Food and Drug Administration yesterday issued draft guidance for cannabis researchers. It is “limited to the development of human drugs and does not cover other FDA-regulated products.” Read

Hawaii wants ban on smokable hemp with new rules sent to governor

7/13/20--The Hawaii Legislature has approved a bill that aligns its hemp testing with federal law and joins other states in banning smokable hemp and CBD-infused edibles. The bill also prohibits hemp from being processed with 500 feet “of a pre-existing playground, school, state park, state recreation area, residential neighborhood, hospital, or daycare facility.” Read

FTC order stops the marketer of “Thrive” supplement from making baseless claims it can treat, prevent, or reduce the risks from COVID-19

7/10/20--The California-based marketer of a supplement called Thrive, which consists mainly of Vitamin C and herbal extracts, is barred from continuing to make baseless claims that it can treat, prevent, or reduce the risk of COVID-19, under an administrative settlement with the Federal Trade Commission announced today. Read

CBD may be legal, but challenges still persist in obtaining CBD product trademark registration

7/7/20--Last week, the Trademark Trial and Appeal Board (TTAB) ruled that a Colorado Cannabidiol (CBD) company could not register a trademark for hemp oil extracts because it violated the Food, Drug & Cosmetics Act (FDCA). Trademark registrations associated with cannabis have repeatedly been refused because they cannot be “lawfully used in commerce." Read

Tobacco users turn to CBD in search of an indicative substitute

6/29/20--According to data provided by the Brightfield Group and published by Hemp Industry Daily, a survey of more than 5,000 CBD users in the U.S. reveals that 24% have used it to help quit smoking and quitters are often replacing cigarettes with either smokable hemp or vaping. And, 41% of quitters have entirely replaced tobacco with hemp CBD. Read

Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada

6/19/20--Results of this qualitative story indicate that parents pursue medical cannabis as a treatment for their children's drug-resistant epilepsy because of a perceived unmet need. However, parents encounter barriers in accessing medical cannabis in Canada, and strategies are needed to ensure that children using medical cannabis receive proper care from healthcare professionals with training in epilepsy care, antiepileptic drugs, and medical cannabis. Read

New Report: CBD companies using “research” as marketing tool could mislead consumers and risk public

6/24/20--Consumers for Safe CBD founding member, National Consumers League (NCL) today released a white paper that explores the great lengths that some unscrupulous CBD manufacturers are taking to sell unregulated, untested products in the marketplace at the risk of public health. This includes trying to legitimize medical claims by leveraging the reputation of academic medical centers—despite the lack of evidence to support those claims. Read

Consumer Brands Association launches Coalition for Smart CBD Regulation

5/21/20--The Consumer Brands Association today announced the launch of the Coalition for Smart CBD Regulation, a cross-industry group committed to protecting consumer safety and advocating for necessary resources and uniform federal policies around cannabidiol (CBD). Read

Analysis on new product launches in Covid-19 related markets-CBD oil market 2020-2024 | Health benefits of CBD oil to boost growth

5/1/20--Technavio has been monitoring the CBD oil market and it is poised to grow by USD 3.52 bn during 2020-2024, progressing at a CAGR of over 32% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Read

CBD Co. settles FTC suit over COVID-19, cancer cure claims

4/29/20--A California CBD and wellness company has agreed to stop marketing vitamin C and herbal extract supplements as able to treat, prevent or cure COVID-19, according to a Federal Trade Commission court filing. If approved by a California federal court, the deal struck Tuesday between Whole Leaf Organics, its owner Marc Ching and the FTC will also bar the company from marketing three CBD supplements as effective cancer treatments. Read

FDA warns companies illegally selling CBD products to treat medical conditions, opioid addiction

4/23/20--The U.S. Food and Drug Administration has issued warning letters to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). Read

In Search of Preventative Strategies: Novel anti-inflammatory high-CBD cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissue

4/19/20--With the rapidly growing pandemic of COVID-19 caused by the new and challenging to treat zoonotic SARS-CoV2 coronavirus, there is an urgent need for new therapies and prevention strategies that can help curtail disease spread and reduce mortality. Read

Consumers for safe CBD calls on media/retailers to help protect consumers

4/9/20--Consumers for Safe CBD sent a letter to major retailers of CBD products and media companies to warn them about the unscrupulous claims that are being made about CBD and COVID-19. As America grapples with the COVID-19 crisis, some CBD manufacturers and stores are beginning to prey on consumers, making false claims that CBD can boost immunity against, or even cure, the coronavirus. Read

Kroger, the largest grocery chain in the US, is lobbying on hemp

2/10/20--Grocery store giant Kroger, which has a large footprint in the midwest and south, is lobbying the federal government on hemp. It's the first company of its kind to do so, and indicated it is lobbying on “issues related to the regulation of topical products containing CBD oils and hemp derived products following the implementation of the 2018 Farm Bill,” according to its Q4 2019 disclosures. Read

The role of cannabidiol (CBD) in chronic pain management: An assessment of current evidence

2/3/20--Given the growing challenges in chronic pain management coupled with the ongoing consequences of the opioid epidemic, pain management practitioners are looking into more effective, innovative, and safer alternatives to treat pain. The use of CBD and its potential role in pain management was investigated by examining recent literature, but based on the available literature, it was deemed difficult to make a recommendation for the use of CBD in chronic pain management. Read

Congressional briefing calls for improved regulation of CBD

12/6/19--On Dec. 5, the National Association of County Behavioral Health & Developmental Disability Directors (NACBHDD), together with the National Association for Rural Mental Health (NARMH) and the National Association of Social Workers (NASW), hosted a Congressional briefing for Hill staff on the need for improved regulation of cannabidiol (CBD) products by the Food and Drug Administration (FDA). Read

Cannabidiol products are everywhere, but should people be using them?

11/20/19--Although the CBD market has exploded in recent months, with products ranging from bath salts to coffee and tea to maple bacon–flavored dog biscuits, research suggests that many actually do not contain CBD. And the compound’s murky status raises a host of questions: Is it safe? Is it effective? Is it legal? Is it a dietary supplement or a drug? Read

CBD interest among Americans surpasses nearly all other health products: ‘This generation’s snake oil’

10/28/19--Cannabidiol, better known as CBD, has undergone a meteoric rise in popularity over recent years. One of the features that makes CBD so appealing is its ability to be ingested or taken in a variety of ways. Still, most major U.S. health leaders, organizations, and departments have remained largely silent on CBD’s proposed benefits mostly due to an overall lack of data on just how popular the oil is, statically. Read

Feds threaten to shut down CBD company for making illegal health claims

10/23/19--The federal government threatened to shut down Rooted Apothecary, of Naples, on Tuesday for illegally claiming its CBD products could treat teething pain, ear aches, autism, ADHD, Parkinson’s, and Alzheimer Disease. The Florida-based patent medicine company was reprimanded for making unsubstantiated claims by the U.S. Food and Drug Administration and the Federal Trade Commission. Read

Are CBD products safe? A new state bill would require lab testing of cannabidiol items.

10/3/19--A bill, from Rep. Bob Morgan, D-Deerfield, would require all CBD products sold in Illinois to meet testing requirements that would be developed by the Illinois Department of Agriculture. Some products put themselves through third-party testing to prove they contain the promised levels of CBD, but there is no standard requirement. Read

Feds warn CBD companies against making unfounded health claims

9/10/19--Several companies that sell products with cannabidiol, or CBD, are facing scrutiny from the Federal Trade Commission for advertising them as treatments for diseases and serious medical conditions without evidence to support the claims. The FTC said Tuesday that it has issued warnings to three companies that sell CBD "gummies," tinctures, oils, capsules and creams, though the agency didn't identify the firms. Read  

Kroger’s Houston-area stores start selling CBD products

8/22/19--As part of a broader company rollout, supermarkets in The Kroger Co.’s Houston division have begun the sale of hemp-derived cannabidiol (CBD) topical products. Kroger said yesterday that CBD lotions, balms, oils and creams are now on shelves at 88 stores in Houston and the surrounding area, as well as online via the Ship.Kroger.com direct-to-customer service and the retailer’s Vitacost.com e-commerce unit. Read

Research Brief: High fat foods can increase CBD absorption into the body

8/12/19--A University of Minnesota study examined whether eating high-fat foods after taking CBD increased the body’s absorption of CBD. The study tested whether fasting or a high fat meal has an effect when cannabidiol oral capsules were taken by patients. The study found CBD exposure is vastly increased when CBD is taken with high fatty foods; when compared to fasting, taking CBD with food increased the amount of CBD in the body by four-times and the maximum amount recorded in the participants’ blood by 14-times. Read

14% of Americans say they use CBD products

8/7/19--One in seven Americans say they personally use cannabidiol- (CBD-) based products, which have proliferated since last year's passage of a federal law legalizing this hemp form of cannabis. Younger Americans and those in the Western U.S. are most likely to report using these products, which are widely touted for their therapeutic benefits without any psychoactive effects because they contain a low level of THC. Read

Tom Hanks denies fake quote promoting CBD company

7/11/19--In a tweet posted on Wednesday morning, Hanks denied a quote attributed to him that described advances in the CBD industry as “remarkable” and stating that he was “feeling like a new me” after using a cannabidiol product from a company called Cali Naturals. For reasons that aren’t entirely clear, Hanks has been featured in several dubious articles in recent years casting him as a champion of the non-intoxicating cannabis compound. Read

Marijuana or hemp: FDA says beware of CBD for these reasons​

7/7/19--The U.S. Food and Drug Administration (FDA) wants the American public to know that cannabidiol (CBD), the non-intoxicating component of the cannabis sativa plant, might not be as safe and effective in the grand scheme of their overall health and wellness as they are being told. The agency wants to clarify a couple of critical points surrounding CBD before more of the public jumps on the bandwagon. Read

Hepatotoxicity of a cannabidiol-rich cannabis extract in the mouse model

4/30/19--The goal of this study was to investigate Cannabidiol (CBD) hepatotoxicity in 8-week-old male B6C3F1 mice. CBD exhibited clear signs of hepatotoxicity, possibly of a cholestatic nature. The involvement of numerous pathways associated with lipid and xenobiotic metabolism raises serious concerns about potential drug interactions as well as the safety of CBD. Read

New medicinal marijuana bill gives many families hope

4/24/19--Governor Kemp has made it legal for up to six private entities to grow marijuana in the state of Georgia for medical purposes only. The bill also signs off on two research centers. Under this new law, medicinal marijuana cannot be advertised, smoked or vaped, and can only be recommended for sixteen different conditions. According to State Representative and doctor, Mark Newton, this law could make a difference for some Georgia families. Read

CBD oil is the new rage among millennials. But, as a doctor, here’s what I worry about

3/23/19--Cannabidiol (CBD) oil is the new rage among millennials and is gaining popularity with all generations, especially in states that have legalized recreational marijuana. According to practicing physician and Fox News medical contributor Nicole Saphier, MD, one of her biggest concerns regarding CBD and many other holistic remedies is that there are some disease processes that require science-driven treatment. Saphier urges everyone to follow their medical doctors’ recommendations regarding treatment of ailments. Read

Medical marijuana in Georgia: legal to have, but illegal to get

3/20/19--The Georgia House approved a bill earlier this month that would allow medical marijuana to be sold to registered patients. Yet, as for getting it from a legal source, patients are on their own. You can’t legally buy it, sell it or bring the drug into Georgia from another state. That could change in the coming weeks if legislators make medical marijuana available not only in theory, but practice too. Read

Texas-based marijuana companies facing flood of cannabis competitors playing under different rules

3/9/19--A flood of unregulated marijuana products is one of the challenges facing Texas’ three medical marijuana companies pioneering a new state industry and trying to turn a profit. The companies want the state to expand the program and crack down on unregulated marijuana products they see as threatening their businesses and the public. According to Heather Fazio, director of Texans for Responsible Marijuana Policy, if lawmakers don’t make changes they risk putting Texas’ fledgling medical marijuana industry out of business. Read

Catoosa Sheriff: Go to Colorado and enjoy marijuana

3/9/19--During a press conference, several Northwest Georgia sheriffs agreed that the Georgia House is “rushing” to pass House Bill 324, allowing for manufacturing of cannabis for production of low-level THC oil. Catoosa County Sheriff Gary Sisk supports their position on being strictly against the bill’s approval. Some of the sheriffs’ concerns stemmed from the opinion that the passing of this bill would be a gateway for legalizing recreational marijuana. Read

Georgia House committee passes medical marijuana bill

3/1/19--A bill proposed by Republican Rep. Micah Gravley of Douglasville moved through a House committee that would that would allow the production and sale of low-potency medical marijuana oil within Georgia. To survive, the bill must pass the full House by Thursday, the deadline for bills to pass out of one legislative chamber. Bills that don't make it past this point are generally considered dead. Yet, the measure's main supporter remains optimistic. Read

KCCI reporter’s mom makes progress with medical marijuana

2/14/19--A car accident gave Terri Clark a lower backache years ago, and she’s been on oxycodone ever since. According to Clark, her doctor noticed how she was scared of being addicted to it, so when it was legalized, her doctor suggested she try legal marijuana, and so far, it has changed her world. At first, she said she didn’t like the feeling that medical marijuana gave her, but that has since gone away. Read

Police give warning on ‘marijuana-like’ CBD flowers

2/15/19--Police are asking retailers to pull products called CBD flowers, focusing on two in particular that are distributed by Indy Hemp Company and Aspen Valley. Both gave positive results in a THC field test. Representatives from both Aspen Valley and the Indy Hemp company told Eyewitness news that, despite the look and smell of their products, everything they sell is in accordance with Indiana’s CBD law. Read

Top states for CBD retail shops?

1/11/19--As legal marijuana is slowly but surely finding its way into the mainstream, the modern pot shop has begun to provide a full-blown brand experience. And while the adoption of pro-marijuana legislation is still in its infancy in the U.S., cannabidiol (or CBD) is essentially available in all 50 states. Remedy Review combed Yelp Reviews to identify 1,000 most populous cities in America with the best-rated shops, the cheapest products, and the markets on the horizon. Read

How recommendation for cannabis oil production could benefit local families

1/4/19--Access to marijuana for medical use in Georgia has remained elusive for families in need. In fact, some patients and their families say they felt forced to break federal and state laws by acquiring the drug in places like California and Colorado, and transporting it back home. The legislative Joint Study Commission on Low THC Medical Oil Access have convened a number of meetings in 2018 to explore how to open access in Georgia to the drug for thousands of registered patients. Read

Hemp seed oil is not CBD oil but tricky marketing fuels consumer confusion

12/12/18--There is a lot of confusion for consumers when shopping for pure CBD oil products. Retail powerhouses, in particular, sell a variety of hemp seed oils, but hemp seeds contain little or no CBD although the marketing for many hemp seed oils often implies otherwise. Therefore, consumers should take the time to do some research since there are only tiny amounts of CBD, if any, present. Hemp seed oil is frequently used for cooking, skin-care products and bio-fuels much like corn oil or other vegetable oils. Read

Iowa’s first medical marijuana dispensary will begin selling products Dec. 1

11/7/18--Iowa’s first medical cannabis manufacturer and dispenser, MedPharm Iowa, is slated to begin selling products on December 1. Upon opening, MedPharm Iowa will offer a total of 14 different products from two dispensaries in the state, one in Sioux City and one in Windsor Heights. Read

Why Is CBD everywhere?

10/27/18--Cannabidiol is being touted as a magical elixir, but according to a New York Times article by writer Alex Williams, it’s hard to say the precise moment when CBD turned into a mainstream panacea. With its proponents claiming that CBD treats ailments as diverse as inflammation, pain, acne, anxiety, insomnia, depression, post-traumatic stress, and even cancer, it’s easy to wonder if this all natural, non-psychotropic and widely available cousin of marijuana represents a cure for the 21st century itself. Read

Concerns raised over lack of guidelines for medics regarding use of substances like cannabis oil

9/13/18--The lack of guidelines to assist medical and nursing staff with the safe use of potentially psychogenic substances, like cannabis oil, has been highlighted by the authors of the Irish Medical Journal (IMJ). Read

Marijuana comes to your coffee and candy—but is it legal?

9/12/18--Companies are selling a growing number of products that contain cannabidiol, or CBD, a chemical found in hemp. It’s being added to everything from gumdrops to beverages, as marketers claim benefits such as pain relief and stress reduction. Read

Underground network brings medical marijuana to Georgia residents, and it’s legal

9/9/18--Georgia is one of the few states that has not provided patients a legal way to access it. Shannon Cloud is part of a quiet network of volunteers meeting in parking lots and fast food restaurants throughout Georgia to legally pass out medical cannabis to those in need. So far, the group’s effort has helped more than 700 patients, but they’re having to start turning people away due to an increase in demand. Read

His seizures stopped when he smoked marijuana. Then he was taken into state custody

9/9/18--While smoking marijuana, David Ray Brill's parents say he went 71 days without a seizure, before one of his doctors alerted DFCS. They immediately made him stop. Shortly thereafter, David was back in the hospital, and his parents were arrested and charged with misdemeanor reckless conduct. In Georgia, patients with nearly a dozen different conditions can get a medical card to take an oil derived from cannabis, but evidently none of his doctors would approve it. Read

CBD company Charlotte’s Web debuts IPO

9/10/18--Colorado-based cannabidiol company, Charlotte’s Web completed its Initial Public Offering in Canada on August 30, 2018. The company’s shares trade on the Canadian Securities Exchange (“CSE”) under the ticker symbol “CWEB” and debuted at C$7.00 (US $5.40) per share. Read

CBD oil helping fight the opioid crisis in Georgia, users say

9/3/18--According to a WSB-TV investigative report, the marijuana product CBD oil is helping Georgians get rid of prescription pain pills because the opioid epidemic is killing people. Currently, cannabis oil is legal for some patients in Georgia, but it is illegal to grow or bring it across state lines. Editors note: Please see Fact Check on this story (fifth story in the September 5, 2018 TMR e-newsletter) hereRead    

Charlotte’s Web and the $100 million IPO

8/31/18--Charlotte’s Web, the producers and distributors of the hemp-based wellness products, went public August 30 with a projected $100 million initial public offering in the Canadian exchange (CWEB). Charlotte’s Web Holdings, Inc. is the producer of Charlotte’s Web, created by Stanley Brothers. While it is certainly not the only high-CBD breed of cannabis on the market, it is the one that’s best known and has garnered a sort of infamy. Read

Families turn to black market; organizations urge better access

8/30/18--Patients who are registered with the state are allowed to possess and use oils that contain ingredients derived from marijuana, including cannabidiol (CBD), THC, the main psychoactive ingredient in marijuana, and THC-acid. Yet, patients have been told by doctors that they can’t help them get the oil, and they want to know how they can get the oil. Rep. Alan Peake, who supports expanded access to marijuana for medical use in Georgia, says patients can go to a legal state, such as Colorado, and smuggle the oil back, but for many, that’s not practical. Other patients or their family members buy marijuana on the street and make the oil at home. Read